You have 9 free searches left this month | for more free features.

Neupogen

Showing 1 - 25 of 379

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Ovarian Insufficiency, Premature Ovarian Failure Trial in Toronto (Neupogen)

Recruiting
  • Primary Ovarian Insufficiency
  • Premature Ovarian Failure
  • Neupogen
  • Toronto, Ontario, Canada
    Trio Fertility
Oct 31, 2023

Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment Trial in Chicago (radiation, drug, procedure)

Completed
  • Multiple Myeloma, Relapsed
  • Multiple Myeloma, Refractory to Standard Treatment
  • Total Marrow Irradiation
  • +3 more
  • Chicago, Illinois
    University of Illinois Cancer Center
Nov 20, 2021

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

Lymphoma, AIDS-related, Lymphoma, Large B-Cell, Diffuse Trial run by the NCI (Rituximab, Filgrastim, EPOCH)

Active, not recruiting
  • Lymphoma, AIDS-related
  • Lymphoma, Large B-Cell, Diffuse
  • Rituximab
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2022

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)

Recruiting
  • Aplastic Anemia
  • Bone Marrow Failure Syndrome
  • Anti-Thymocyte Globulin (Rabbit)
  • +8 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 26, 2022

Medulloblastoma Trial in Memphis (procedure, drug, radiation)

Recruiting
  • Medulloblastoma
  • Surgical resection
  • +11 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Sep 16, 2022

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Breast Cancer Trial in Bandung (Leucostim 5µg/kg/day, Neupogen 5µg/kg/day)

Completed
  • Breast Cancer
  • Leucostim 5µg/kg/day
  • Neupogen 5µg/kg/day
  • Bandung, Indonesia
    RSUP Dr. Hasan Sadikin
Dec 24, 2020

Crohn Disease Trial in Los Angeles (drug, procedure, biological)

Recruiting
  • Crohn Disease
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 23, 2022

Cervix Cancer, Endometrial Cancer Trial in Stanford (FDG PET/CT, GCSF)

Recruiting
  • Cervix Cancer
  • Endometrial Cancer
  • Stanford, California
    Stanford Cancer Institute Palo Alto
Feb 11, 2022

Critical Limb Ischemia Trial in Chicago (Pneumatic calf compression, Filgrastim)

Completed
  • Critical Limb Ischemia
  • Chicago, Illinois
    University of Illinois at Chicago
Nov 10, 2021

Retinoblastoma Trial in Memphis (drug, other, procedure, radiation)

Recruiting
  • Retinoblastoma
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 25, 2022

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)

Completed
  • Prostate Cancer
  • San Francisco, California
  • +5 more
Aug 9, 2022

Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

Active, not recruiting
  • Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Idiopathic Pulmonary Fibrosis, Emphysema or COPD Trial in Pittsburgh (CD3/CD19 negative hematopoietic stem cells, Rituximab,

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Emphysema or COPD
  • CD3/CD19 negative hematopoietic stem cells
  • +6 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Retinoblastoma, Retinal Tumor Trial in Memphis (procedure, drug, radiation, other)

Active, not recruiting
  • Retinoblastoma
  • Retinal Neoplasm
  • Enucleation
  • +9 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 10, 2022

Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

Recruiting
  • Crohn's Disease
  • autologous CD34-selected peripheral blood stem cells transplant
  • +8 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,

Recruiting
  • Systemic Sclerosis
  • +3 more
  • Pittsburgh, Pennsylvania
  • +2 more
Dec 17, 2021

AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the

Active, not recruiting
  • AIDS-Related Burkitt Lymphoma
  • +5 more
  • Bethesda, Maryland
    NCI Lymphoid Malignancies Branch
Jul 31, 2022

Mantle-Cell Lymphoma Trial in Miami (G-CSF, Rituximab, Cyclophosphamide)

Active, not recruiting
  • Mantle-Cell Lymphoma
  • G-CSF
  • +10 more
  • Miami, Florida
    University of Miami
Aug 12, 2021

G-CSF Use in Breast Cancer, Lung Cancer, or Lymphoma Treated

Completed
  • Breast Cancer
  • Lung Cancer
  • filgrastim, TBO-filgrastim or pegfilgrastim
  • (no location specified)
Jul 24, 2021

Early-stage Breast Cancer Trial in Ottawa (Filgrastim, Pegfilgrastim)

Recruiting
  • Early-stage Breast Cancer
  • Ottawa, Ontario, Canada
    Ottawa Hospital Research Institute
Jun 10, 2021